MARATTO

article · Healthcare Analytics

A hybrid model for post-treatment mortality rate classification of patients with breast cancer

20239 citationsOpen accessOsun State University

Abstract

Terminal cancer is not curable and eventually results in death. Breast cancer (BC) is a prevalent malignancy affecting women. Although there are prognostic indicators, BC prognosis is still challenging because of the intricate connections between various survival factors and influencing factors. This study proposes an ensemble classifier for predicting BC survivability using a new BC post-treatment dataset for the number of survivals. However, the classes survival cases dataset for BC is skewed, which caused a sub-optimal classification performance. Hence, a hybrid sampling scheme of Synthetic Minority Over-Sampling TEchnique (SMOTE) and Wilson's Edited Nearest Neighbor (ENN) is employed to treat the class imbalance in the dataset. Random Forest (RF) ensemble classifier is for classifying the dataset. The proposed framework performs well in terms of accuracy, recall of the two classes, Receiver Operating Characteristics (ROC) and Kappa Statistic (KS) metric on the dataset. The results demonstrated that the RF, with 97.0% accuracy on the holdout sample, is the best predictor. This prediction accuracy is superior to any noted in the literature, compared with Logistic Regression (LR) and Bagging classifiers.

Research topics

  • AI in cancer detection
  • Artificial Intelligence in Healthcare
  • Imbalanced Data Classification Techniques

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.health.2023.100254

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.